We are live on
!
Find out more
AHS
Aspiriant Holdings S3 Portfolio holdings
AUM
$233M
1-Year Est. Return
3.13%
This Fund
S&P 500
This Quarter
Est. Return
+8.52%
1 Year Est. Return
-3.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$254M
AUM Growth
+$17.5M
(+7.4%)
Cap. Flow
-$1.13M
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
25.16%
Holding
107
New
5
Increased
27
Reduced
66
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$3.79M |
| 2 |
Baxter International
BAX
|
+$405K |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$365K |
| 4 |
Schwab US Mid-Cap ETF
SCHM
|
+$207K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$207K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$3.33M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$663K |
| 3 |
SPDR Gold Trust
GLD
|
+$548K |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$316K |
| 5 |
Apple
AAPL
|
+$171K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.36% |
| 2 | Technology | 11.58% |
| 3 | Healthcare | 9.15% |
| 4 | Communication Services | 8.21% |
| 5 | Energy | 7.92% |
Similar funds
SFU
BL
KM
TC
IA
QA
THP
SGH
Aspiriant Holdings S3's Q4 2013 Portfolio in Review
As of Q4 2013, Aspiriant Holdings S3 held 107 positions worth $254M, up 7.4% from $237M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Aspiriant Holdings S3's Q4 2013 filing shows 5 new, 27 increased, 66 reduced and 1 closed positions. Its largest new stake was Comcast: 157,448 shares worth $4.09M. The largest sale was IBM, an estimated $3.33M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.
- Aspiriant Holdings S3's largest Q4 2013 buy was Comcast: 157,448 shares worth $4.09M.
- Aspiriant Holdings S3 added most to Vanguard S&P 500 ETF in Q4 2013, an estimated $365K increase.
- Aspiriant Holdings S3's biggest Q4 2013 reduction was IBM, cutting an estimated $3.33M.
- Aspiriant Holdings S3 fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $663K.
- Aspiriant Holdings S3's ten largest holdings make up 25% of its $254M portfolio in Q4 2013.
- Aspiriant Holdings S3 opened 5 new positions and closed 1 in Q4 2013.
- Aspiriant Holdings S3's portfolio value rose 7.4% quarter-over-quarter to $254M.
Based on Aspiriant Holdings S3's 13F filing for Q4 2013, filed 3 Feb 2014.